-
Resources from Canada
CPFF: Clinical trials for new PF treatments in 2024 and beyond Government of Canada: Clinical Trials and Drug Safety In Canada Health Canada: Clinical Trials and Health Safety: download the pdf Find a Clinical Trial in Canada The Canadian Pulmonary Fibrosis Foundation (CPFF) is committed to providing valuable resources to our community. Click here to find a…
-
Resources from the United States
Pulmonary Fibrosis Organization has a Clinical Trial Finder for pulmonary fibrosis related to conditions https://www.pulmonaryfibrosis.org/patients-caregivers/medical-and-support-resources/clinical-trials-education-center ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world The Center for Information and Study on Clinical Research Participation (CISCRP) Informing patients and families about clinical research: The Center for Information and Study on…
-
Find a Clinical Trial for Pulmonary Fibrosis
The Canadian Pulmonary Fibrosis Foundation (CPFF) is committed to providing valuable resources to our community. Click here to find a list of the most recent clinical trials evaluating new pulmonary fibrosis research in Canada. The PF Foundation clinical trials education centre from the United States also offers a clinical trial finder and more
-
FIBRONEER-IPF: A Phase 3 Clinical Trial – Dr. Donald Zoz
FIBRONEER-IPF: A Phase 3 Clinical Trial – Dr. Donald Zoz This presentation, led by Dr. Donald Zoz MD, senior clinical program leader at Boehringer Ingelheim, provides some insight into FIBRONEER-IPF, a Phase 3 Clinical Trial. The goal of FIBRONEER-IPF Phase 3 Clinical Trial is to evaluate the efficacy, safety, and tolerability of the compound BI…
-
Living with PF Helpful links
Government of Canada Benefits Finder This online Benefits Finder may suggest benefits from federal, provincial, or territorial governments, and does not collect or track your information. Living with PF Resources UHN IPF Information for patients and families inIPF.com by Boehringer Ingelheim Pharmaceutical Treatment Information UHN Handout – Pirfenidone (Esbriet™) – Information for patients UHN Handout…
-
Tackle the Crackle©
Pulmonary fibrosis (PF) is often difficult to diagnose, with patients waiting an average of two years for a confirmed diagnosis. Early symptoms can be subtle and mistaken for other lung conditions. These Tackle the Crackle© resources support early detection, help you prepare for conversations with your healthcare team, and connect you with PF specialists and…
-
Oxygen Therapy Resource Library
These oxygen therapy resources can help you learn more about oxygen therapy benefits, using oxygen systems, and traveling with oxygen. Supplemental Oxygen Resources Learn about supplemental oxygen benefits, oxygen therapy systems and more Oxygen is Medicine Campaign Overview: Learn why oxygen should be classified as an essential medicine Pulmonary Fibrosis Patient Guide : Learn about pulmonary…
-
Drug Coverage by Province
British Columbia – Pirfenidone – Nintedanib Alberta – Pirfenidone – Nintedanib Manitoba – Pirfenidone & Nintedanib (See page 81) Saskatchewan – Pirfenidone & Nintadanib (See pages 62-69) Ontario – Pirfenidone & Nintedanib (See pages 374-376) Quebec – Pirfenidone & Ninedanib – English (See pages 117 & 129) / Français (Voir pages 125 et 137) New Brunswick – Pirfenidone & Ninedanib –…
-
Breathe Right Exercise Program Video Series
Jill Lommer is an exercise rehabilitation therapist who is leading the Breathe Right Exercise Program funded by BC Lung Foundation. Jill is experienced in supporting those living with COPD and other chronic lung conditions. In every class, Jill will include a warm-up, cardio, strength training, and cool down stretches. Suitable for all fitness levels. CLICK…
-
